An ECB rate hike is ‘all but certain’ — but investors divided on what comes next
The central bank is contending with rising prices, the consequences of the U.S.-Iran war, and surging government borrowing costs.
CNBC World - 2026-09-10 05:00:02UBS CEO flags investor complacency as geopolitical and economic risks mount
The UBS top boss cautioned that investors face an increasingly complicated environment given multiple headwinds.
CNBC World - 2026-09-10 02:52:55Surging Crude Prices Are Supportive for Sugar
October NY world sugar #11 (SBV26 ) is up +0.19 (+1.05%) today, and October London ICE white sugar #5 (SWV26 ) is up +8.00 (+1.54%). Sugar prices are moving higher today on the +3% surge in crude price (CLV26 ) to a 3.25-month high. Higher crude prices support ethanol prices...
Nasdaq Stocks - 2026-09-10 02:26:05Leerink Partners Initiates Coverage of Nautilus Biotechnology with Outperform
Fintel reports that on September 9, 2026, Leerink Partners initiated coverage of Nautilus Biotechnology (NASDAQCM:NAUT) with a Outperform recommendation.Prior to this rating action, the stock closed at $0.93 on September 8, 2026. This represents a one-week price change of +0.15%
Nasdaq Stocks - 2026-09-10 02:19:54Wells Fargo Upgrades Martin Marietta Materials to Overweight from Equal-Weight
Fintel reports that on September 9, 2026, Wells Fargo upgraded their outlook for Martin Marietta Materials (NYSE:MLM) from Equal-Weight to Overweight. This rating action follows a prior action on July 31, 2026, when Wells Fargo maintained its Equal-Weight rating. Other recent ana
Nasdaq Stocks - 2026-09-10 02:19:19Coca-Cola CEO Braun Targets Growth With Digital, Consumer Insights and Innovation
Safety Stocks Are Not What They Used to Be: 4 Names Built for a Weaker DollarHenrique Braun, chief executive officer of The Coca-Cola Company (NYSE:KO), said his early focus in the role has been maintaining the company’s operating momentum while advancing priorities centered on c
Nasdaq Earnings - 2026-09-10 02:02:15Leerink Partners Initiates Coverage of Amneal Pharmaceuticals at Outperform
Fintel reports that on September 9, 2026, Leerink Partners initiated coverage of Amneal Pharmaceuticals (NASDAQGS:AMRX) with a Outperform recommendation. This initiation occurred on September 9, 2026, a day when the stock closed at $17.27, following a pre-action close of $17.05 o
Nasdaq Stocks - 2026-09-10 01:57:44